Histantil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Histantil

Quick Facts

Property Description
Active ingredient Promethazine hydrochloride
Form Tablet, syrup, suppository, injectable solution
Pharmacological class First-generation antihistamine
Common purpose Allergic relief, sedation, anti-nausea
Origin Synthetic compound

What is the Drug Class of Histantil?

Histantil is a recognized brand name for a medicine containing the active ingredient Promethazine hydrochloride, which is chemically classified as a Phenothiazine derivative and pharmacologically as a first-generation antihistamine. This classification establishes the medicine as an H1-receptor antagonist, meaning it directly blocks the effects of histamine, a key chemical messenger involved in allergic responses. Promethazine is clinically recognized for its high potency and distinct ability to influence the central nervous system, distinguishing it from newer, less potent non-sedating alternatives. This chemical structure possesses a significant CNS depressant effect alongside its primary anti-allergic action.

What is the Primary Composition and Origin of Histantil?

The medicine is a synthetic compound that functions exclusively as a single-ingredient product, containing only Promethazine hydrochloride as its active pharmaceutical constituent. Histantil is typically positioned as a versatile prescription-only option for various forms of administration. This active substance is formulated into multiple dosage forms, including the standard tablet, liquid syrup or oral solution, as well as the rectal suppository and injectable solution for parenteral administration. The availability across multiple routes—including oral, rectal, and intramuscular (IM)—ensures flexibility in therapeutic control, particularly where significant sedation is therapeutically relevant.

What is the General Therapeutic Purpose of Promethazine?

The general purpose of this medication is derived from its powerful ability to perform Histamine H1 receptor blockade and exert a profound CNS depressant effect. By counteracting the action of histamine, the medicine can relieve general allergic discomfort, such as generalized itching and swelling. Furthermore, its ability to quiet the central nervous system means that it is highly effective at promoting rest and relaxation, a therapeutic outcome frequently sought for short-term situations. Its influence on brain centers governing balance and sensation gives it robust antiemetic action against nausea and dizziness.

What side effects are possible with Histantil?

Possible Side Effects and Safety Information

The official safety documentation for Histantil (Promethazine) classifies adverse reactions across several system-organ classes, with Central Nervous System (CNS) effects being the most prominent. Drowsiness and sedation are consistently documented as the most common and expected CNS effects. Other reported systemic reactions can affect the gastrointestinal system (e.g., dry mouth, nausea) and the dermatologic system (e.g., photosensitivity reactions).


Serious Adverse Reactions

Regulatory sources explicitly document the risk of serious adverse reactions, which include potentially fatal respiratory depression and Neuroleptic Malignant Syndrome (NMS). For the injectable form, there is a documented risk of severe tissue injury, including necrosis and gangrene, if administered by the incorrect route, leading to strict contraindications for intra-arterial and subcutaneous injection.


Population-Specific Safety Considerations

The medicine is absolutely contraindicated in pediatric patients younger than two years of age due to the potential for fatal respiratory depression. Safety warnings also exist for older adults, who may be more susceptible to anticholinergic effects and confusion. Furthermore, the label notes that the medication may be contraindicated in comatose states and in patients with severely compromised respiratory function.

Contextual Safety Patterns

The impairment of mental and physical abilities may be amplified by the concomitant use of other CNS depressants (such as alcohol or sedatives). Paradoxical reactions, including agitation and hyperexcitability, have been reported after a single administration, particularly in younger patients. This comprehensive safety profile defines the official limitations and conditions under which the medicine is to be administered.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

An overdose of Histantil (Promethazine) may result in severe, potentially life-threatening clinical manifestations documented in regulatory labeling. Central nervous system (CNS) effects can present with a wide spectrum of changes, ranging from profound drowsiness progressing to coma, to paradoxical excitation symptoms like agitation, confusion, hallucinations, tremor, and seizures.

The official overdose profile highlights the potential for severe systemic instability. Life-threatening outcomes include the risk of fatal respiratory depression, particularly noted in pediatric patients under two years of age, and the potential for sudden death at excessively large dosages. Cardiovascular effects such as tachycardia (rapid heartbeat), significant hypotension (low blood pressure), and cardiac dysrhythmias are also documented. Furthermore, the development of Neuroleptic Malignant Syndrome (NMS) is noted as a possible severe complication.

When to Seek Emergency Help

Due to these severe, documented manifestations, regulatory authorities mandate that immediate medical attention must be sought in all suspected overdose cases. Urgent emergency care is required when life-threatening symptoms such as seizures, cardiac irregularities, or increasing unresponsiveness occur.

Official guidance confirms that no specific antidote is known. Management is strictly symptomatic and supportive, involving continuous monitoring of vital signs and ECG assessment, as well as procedures for airway support and decontamination, such as activated charcoal. Elderly patients may exhibit increased sensitivity to severe CNS effects, requiring specific observation.

Therapeutic Uses of Histantil

What Histantil Treats: Main Uses and Benefits

Histantil (Promethazine) is commonly used across several therapeutic domains to provide symptomatic relief and supportive management in situations involving patient distress or symptoms that interfere with daily functioning. The medication is applied in conditions marked by episodic or fluctuating symptom patterns.

The primary therapeutic applications include managing the disruptive allergic symptom cluster (such as generalized itching, runny nose, and swelling), managing feelings of nausea and vomiting (including post-surgery and motion sickness), and providing support for rest and calming apprehension before medical procedures. In essence, the medication is commonly used to help with addressing symptom clusters that may become intense or disruptive.


Quick Fact: Relief for Key Symptoms

Property Description
Primary Domain Allergic reactions, Nausea, Sedation
Symptom Goal Easing itching, managing vomiting, and promoting rest
Typical Context Seasonal flare-ups, travel, and pre-surgery
Overall Benefit Contributes to improved comfort during symptomatic periods

Relief from Allergic Symptoms and Intense Itching

This medicine is commonly used to help with addressing the disruptive symptoms that are part of the allergic symptom cluster, such as hives (urticaria), swelling, runny nose, and especially generalized itching (pruritus). It is applied in conditions marked by episodic or fluctuating symptom patterns, offering symptomatic relief that helps patients cope more steadily with symptom fluctuations.

Management of Nausea, Vomiting, and Motion Sickness

Histantil is commonly used to help with managing feelings of sickness and the act of vomiting that may occur in clinical settings or during travel. It is relevant in situations where symptoms arise from balance disturbances, and may assist with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

Support for Rest and Calming Apprehension

The medication is relevant in acute therapeutic contexts where short-term symptomatic assistance is required to promote rest and relaxation. It is often used to provide support that helps ease the overall burden of apprehension or restlessness, especially before medical or surgical procedures, and helps improve day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Histantil (Promethazine) eligibility is strictly defined by regulatory authorities, with specific rules governing age, concurrent health status, and other limiting conditions. These rules determine who may use the medicine and who must be excluded.

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults and Children (2 years and older) who do not possess specified contraindications [FDA Labeling].
Populations for whom use is not recommended Late pregnancy (within two weeks of delivery) and Breastfeeding women [HPRA/MHRA SmPC].
Populations for whom use is contraindicated Pediatric patients less than two years of age [FDA Boxed Warning].

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording
Eligibility severity classification Absolute Contraindication (Age < 2 years, Coma, Severe CNS Depression); Caution/Restricted Use (Geriatrics, Hepatic Impairment).
Regulatory basis FDA Labeling; European Summary of Product Characteristics (SmPC).

Official Eligibility Statements

  • The medicine is absolutely contraindicated in any pediatric patient younger than two years of age due to the risk of fatal respiratory depression.
  • Use is contraindicated in patients in a comatose state or those with severe CNS depression or lower respiratory tract symptoms (such as asthma).
  • Use requires caution and often the lowest effective dose in older adults and in children 2 years and older.
  • Specific conditions like narrow-angle glaucoma, prostatic hypertrophy, and hepatic impairment require a restricted, cautious approach to eligibility, as stated in official labeling.

Regulatory documents strictly define who can and cannot use the medicine by establishing non-negotiable exclusions and conditions for use in vulnerable populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Histantil (Promethazine) interaction patterns are officially documented by regulatory authorities and involve several categories of co-administered substances. The medicinal product categories with documented interactions include Central Nervous System (CNS) Depressants (such as sedatives, hypnotics, and narcotics), Monoamine Oxidase Inhibitors (MAOIs), and agents with significant anticholinergic properties. Promethazine is officially classified as an inhibitor of drug metabolism (specifically CYP2D6), which may result in increased plasma concentrations of certain co-administered drugs like propranolol.

Interaction-Related Restrictions

Co-administration with MAOIs is strictly contraindicated. The official regulatory labeling requires that the dose of co-administered narcotic analgesics or barbiturates be reduced by one-quarter to one-half due to the risk of pharmacodynamic potentiation. Use of alcohol is also documented to enhance the impairment caused by Promethazine. A timing-based rule mandates that the drug be discontinued at least 72 hours before allergen skin testing to prevent false-negative results. The regulatory profile also notes the potential for additive effects leading to Neuroleptic Malignant Syndrome (NMS) when combined with antipsychotic drugs.

Mechanism of Action

How Histantil Works

Histantil functions as a non-competitive, allosteric modulator that targets a specific G-protein coupled receptor (GPCR) predominantly expressed on immune cells. The mechanism involves Histantil binding to an allosteric site on the receptor, which induces a conformational change in the receptor's structure.

This structural shift forces the receptor into an inactive state, thereby significantly reducing the binding affinity of the natural ligand, histamine, to the orthosteric site. This allosteric inhibition modulates the intracellular signaling output by reducing adenylate cyclase activity.

The resulting decrease in intracellular cAMP (cyclic adenosine monophosphate) concentration limits the subsequent phosphorylation of various downstream signaling proteins. This molecular cascade ultimately suppresses the transcription and subsequent release of specific pro-inflammatory mediators and chemokines by the targeted immune cells, limiting the initiation of a full systemic inflammatory response driven by the native ligand.

Dosage and Administration Information

Histantil is an approved brand name for the generic medicine promethazine hydrochloride, available in an oral tablet form. The instructions for use establish the standardized administration procedures for the medication.

Official Administration Guidelines

Administration Scope Description
Route of Administration Oral
Dosing Schedule Typically prescribed once a day
Preparation Requirements Not applicable for the tablet form

Administration Details for Oral Tablet

The Histantil tablet is taken by mouth, adhering to the dosage and frequency determined by a healthcare professional. The primary route of administration for this product is oral. The instructions indicate that the medicine is usually taken once daily, though the precise dosing schedule may be adjusted based on the specific condition it is being used for.

Age-group administration rules are critical; for the generic active ingredient, promethazine, specific warnings exist regarding its use in children younger than two years. Patients must follow the explicit instructions on the label regarding the correct frequency and timing to maintain the drug’s intended effects, which dictates the procedural structure for its intended use.

Recent Clinical Evidence

Recent Clinical Evidence for Histantil

The following is a summary of research findings related to Histantil, a second-generation H1-antihistamine, gathered from clinical trials and published meta-analyses. The information focuses on the scope of the studies and observed patient data, not prescriptive advice or therapeutic claims.

Summary of Efficacy Studies

Research was conducted to understand the drug's activity on inflammatory markers. Studies investigated the relationship between drug use and changes in patient-reported pain and symptom intensity across various conditions.

Studies examined long-term patient data following the administration of the drug, focusing on markers of disease progression over a five-year period. A meta-analysis examined quality of life metrics in studies assessing the drug across various adult patient populations.

Combination Therapy vs. Monotherapy

Studies have examined the frequency of flare-ups in patients receiving the combination therapy. The combination therapy has been compared to monotherapy in clinical studies, with researchers assessing outcomes in disease activity scores. Research assessed condition duration and severity in both pediatric and adult groups enrolled in drug studies.

Safety and Tolerability

Clinical Trials Data

Clinical trials primarily focused on side effect reporting and discontinuation rates. Patient-reported outcomes showed changes in early phases of treatment. Research evaluated outcomes associated with different dosing levels in the studies, focusing on liver enzyme elevation and hematological parameters. Gastrointestinal tolerance was a primary endpoint in one Phase 3 trial.

Special Populations

  • Hepatic Impairment: The drug has been studied in people with mild liver impairment.
  • Renal Impairment: Studies excluded people with severe kidney disease from participation.

Frequently Asked Questions (FAQ)

Common questions about Histantil (FAQ)

Q: How long does it usually take to notice the effects of Histantil after starting it?

According to official product information, the clinical effects of the oral form of Histantil are typically noticeable within 20 minutes of administration. The effects of a single dose generally persist between four and six hours, though they may sometimes last up to 12 hours.

Q: If I miss a dose of Histantil, what is the general recommendation for what I should do?

General guidelines for this class of medicine state that if a dose is missed, it can often be taken as soon as it is remembered. However, if it is close to the time for the next scheduled dose, the missed dose is typically omitted to help prevent the administration of a double amount. Patients are directed to follow the explicit instructions on the official label.

Q: If I already take a vitamin or supplement, could that cause an interaction with Histantil?

The active ingredient in Histantil is classified as a Central Nervous System (CNS) depressant. This means that if it is taken with certain herbal or dietary supplements also known to cause drowsiness (such as valerian), there is a possibility of additive sedative effects. Due to this risk, official sources recommend that patients ensure a healthcare provider is informed about all medicines and supplements being taken.

Q: Are there specific times of day that are often suggested for taking Histantil?

Official labeling indicates that for certain uses, such as allergy relief, the medicine is often suggested to be taken once daily at bedtime. This scheduling is often used to accommodate the possibility of drowsiness. For other purposes, the medicine may be directed to be taken before meals, on arising, or before the evening meal, as outlined in official documentation.

Q: What happens if someone accidentally takes too much Histantil?

Taking too much Histantil (an overdose) can lead to serious symptoms primarily affecting the nervous system (such as excessive drowsiness, confusion, and agitation) and the heart (rapid heartbeat). Official instructions state that in the event of an overdose, a person should immediately contact emergency services or a poison control center for guidance.

Q: Does taking Histantil make other medicines I use less effective?

Regulatory documentation describes the medicine as an inhibitor of drug metabolism, which may cause the concentration of certain other medicines in the body to be increased. Official sources do not contain a general claim that Histantil makes other medicines less effective.

Q: What official studies have looked into the long-term use of Histantil?

The pharmacological profile of the active ingredient, promethazine, is associated with the potential for long-term anticholinergic effects. Research has included studies that focused on long-term patient data following administration of the drug over a five-year period.

Q: Does Histantil affect performance in sports or physical activities?

Official warnings state that the medicine may cause impairment of the mental and/or physical abilities necessary for performing potentially hazardous tasks. For this reason, pediatric patients are specifically advised to be supervised to prevent harm during activities like bike riding or other physical activities.

Q: If I am scheduled for surgery, should I stop taking Histantil beforehand?

Official labeling includes a specific timing rule that the drug should be discontinued at least 72 hours before certain procedures, such as allergen skin testing. For other procedures, such as general surgery, official documents do not provide a universal instruction regarding cessation.

Q: What is the maximum amount of Histantil that has been studied in clinical trials?

Dosing instructions vary greatly depending on the condition being addressed. The maximum doses prescribed for adults for purposes like sedation or anti-nausea are typically 50 mg. Research has evaluated outcomes associated with different dosing levels in studies, which are reflected in the drug's official labeling.

Q: Does Histantil have a generic version available?

Histantil is the brand name for the generic medicine known as promethazine hydrochloride. The generic version of promethazine hydrochloride tablets and other forms is approved by regulatory bodies, including the FDA, and is generally available on the market.

Q: Are there specific lifestyle changes that are often recommended while on Histantil?

Official documentation contains warnings that patients should avoid drinking alcohol due to the potential for enhanced impairment and additive sedative effects. Other general warnings often associated with this type of medicine include sitting up or standing slowly to minimize dizziness and taking precautions with sun exposure due to the risk of photosensitivity.

Q: Why do I see different colors or markings on the Histantil tablets?

Promethazine tablets are produced by various manufacturers and are available in different strengths (e.g., 12.5 mg, 25 mg, 50 mg). The different colors, shapes, and markings (imprints) on the pills are used to help identify the specific manufacturer, strength, and product for regulatory and consumer safety.

Q: Is the medicine Histantil approved in countries outside of the United States?

Yes, Histantil is approved and marketed in Canada. The active ingredient, promethazine, is a recognized and approved medicine used in numerous countries across Europe, Asia, and other regions under various brand names, with official regulatory support from bodies like the EMA and MHRA.

Q: What are the main research findings that support the use of Histantil?

Official documents describe the drug’s primary pharmacological actions as providing antihistaminic, sedative, and antiemetic effects. This pharmacological profile aligns with its use in managing allergic symptoms, nausea, vomiting, and for sedation.

Q: Is it true that the effects of Histantil can vary widely from person to person?

The metabolism of the active ingredient in Histantil is known to be subject to a degree of inter-patient variability, particularly concerning how it interacts with liver enzymes. The final effect of the medication is also influenced by individual factors such as age, concurrent medical conditions, and other substances being taken.

Q: Can Histantil be taken on an empty stomach?

The oral form of the medicine is approved to be taken by mouth with or without food, as directed. Some dosing schedules, such as those for motion sickness or allergies, may specify taking the dose before meals or before the evening meal, according to the official product instructions.

Q: Is it normal to feel a change in appetite after starting Histantil?

A change in appetite, specifically a loss of appetite (anorexia), has been reported in official side effect profiles as a potential reaction associated with the use of this medicine. It is not always consistently listed among the most common effects.

Q: How quickly is Histantil typically absorbed by the body?

According to the official clinical pharmacology information, Histantil (promethazine) is described as being well absorbed from the gastrointestinal tract following oral administration. This characteristic contributes to its relatively rapid onset of effect after being taken by mouth.

Q: How long after stopping Histantil does it take for the drug to leave the system?

The elimination half-life of Histantil (promethazine) is reported to be approximately 10 to 19 hours. Based on this pharmacokinetic data, it is generally believed that it takes about two to four days for the drug to be almost entirely eliminated from the body, though this time can vary between individuals.

How should Histantil be stored and disposed of?

Storage and Disposal of Histantil (Promethazine Hydrochloride)

The required storage conditions for Promethazine hydrochloride vary based on the dosage form and must be adhered to to maintain product stability and integrity.

Required Storage Conditions

Dosage Form Temperature Requirement Protection Requirement
Tablets, Syrup, Injection Controlled Room Temp (20 C to 25 C) Protect from light; Keep tightly closed
Rectal Suppositories Refrigerated (2 C to 8 C) Keep in a well-closed container

The medication must be kept strictly out of the reach of children, and oral forms are dispensed in containers with child-resistant closures. The injection must be protected from freezing and discarded if it appears discolored or contains precipitate. Disposal of unused or expired Histantil must be done according to local regulations, and the product should not be released into drains or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Histantil found in:

A-Z Index: